Skip to main content
Top
Published in: Reactions Weekly 1/2023

01-12-2023 | Neutropenia | Case report

Carboplatin/Pembrolizumab/Pemetrexed

Various toxicities: case report

Published in: Reactions Weekly | Issue 1/2023

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Mughal HA, et al. Treatment of induced oligometastatic disease after partial response to immunochemotherapy in patient with stage IV non-small cell lung cancer and severe toxicity. BMJ Case Reports 15: 1-5, No. 12, 14 Dec 2022. Available from: URL: http://casereports.bmj.com/ Mughal HA, et al. Treatment of induced oligometastatic disease after partial response to immunochemotherapy in patient with stage IV non-small cell lung cancer and severe toxicity. BMJ Case Reports 15: 1-5, No. 12, 14 Dec 2022. Available from: URL: http://​casereports.​bmj.​com/​
Metadata
Title
Carboplatin/Pembrolizumab/Pemetrexed
Various toxicities: case report
Publication date
01-12-2023
Publisher
Springer International Publishing
Keyword
Neutropenia
Published in
Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-51428-5

Other articles of this Issue 1/2023

Reactions Weekly 1/2023 Go to the issue

Case report

Heparin

Case report

Lenvatinib

Case report

Ibrutinib

Case report

Dexmedetomidine